Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Multiple pharmaceutical agents in clinical trials promise to offer patients eye drops for the management of presbyopia.

A new study has shown that evidence of genetic susceptibility to schizophrenia can be found in the retina. This finding could help improve the early detection of the disorder.